BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35885614)

  • 1. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
    Lebensohn A; Ghafoor A; Bloomquist L; Royer MC; Castelo-Soccio L; Karacki K; Hathaway O; Maglo T; Wagner C; Agra MG; Blakely AM; Schrump DS; Hassan R; Cowen EW
    JAMA Dermatol; 2024 May; ():. PubMed ID: 38759225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series.
    Miranda J; Dave P; Kemel Y; Sheikh R; Zong G; Calderon LP; Will M; Liu YL; Walsh M; Stadler ZK; Offit K; Latham A; Mandelker D; Chen YB; Andrieu PC; Carlo MI
    Eur J Hum Genet; 2024 Jun; ():. PubMed ID: 38824259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterisation guides classification of novel
    Hong JH; Chong ST; Lee PH; Tan J; Heng HL; Ishak NDB; Chan SH; Teh BT; Ngeow J
    NPJ Genom Med; 2020; 5():50. PubMed ID: 33240524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.
    Rossi G; Righi L; Barbisan F; Tiseo M; Spagnolo P; Grosso F; Pisapia P; Malapelle U; Sculco M; Dianzani I; Abate-Daga L; Davolio MC; Ceresoli GL; Galetta D; Pasello G; Novello S; Bironzo P
    J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Primary Cancers in a Population-Based Mesothelioma Registry.
    Mensi C; Stella S; Dallari B; Rugarli S; Pesatori AC; Ceresoli GL; Consonni D
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Italian Experience in the Development of Mesothelioma Registries: A Pathway for Other Countries to Address the Negative Legacy of Asbestos.
    Magnani C; Mensi C; Binazzi A; Marsili D; Grosso F; Ramos-Bonilla JP; Ferrante D; Migliore E; Mirabelli D; Terracini B; Consonni D; Degiovanni D; Lia M; Cely-García MF; Giraldo M; Lysaniuk B; Comba P; Marinaccio A
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    Tesch ME; Pater JA; Vandekerkhove G; Wang G; Binnington K; So AI; Wyatt AW; Eigl BJ
    NPJ Genom Med; 2020; 5():12. PubMed ID: 32218990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics of
    Sculco M; La Vecchia M; Aspesi A; Clavenna MG; Salvo M; Borgonovi G; Pittaro A; Witel G; Napoli F; Listì A; Grosso F; Libener R; Maconi A; Rena O; Boldorini R; Giachino D; Bironzo P; Maffè A; Alì G; Elefanti L; Menin C; Righi L; Tampieri C; Scagliotti GV; Dianzani C; Ferrante D; Migliore E; Magnani C; Mirabelli D; Matullo G; Dianzani I
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP1 germline variants in Finnish patients with malignant mesothelioma.
    Repo P; Staskiewicz A; Sutinen E; Rönty M; Tero T Kivelä ; Myllärniemi M; Turunen JA
    Lung Cancer; 2022 Mar; 165():102-107. PubMed ID: 35114507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.
    Chau C; van Doorn R; van Poppelen NM; van der Stoep N; Mensenkamp AR; Sijmons RH; van Paassen BW; van den Ouweland AMW; Naus NC; van der Hout AH; Potjer TP; Bleeker FE; Wevers MR; van Hest LP; Jongmans MCJ; Marinkovic M; Bleeker JC; Jager MJ; Luyten GPM; Nielsen M
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382694
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.